NASDAQ:SGP Spyglass Pharma Q3 2026 Earnings Results & Report $34.25 -0.72 (-2.06%) As of 10:04 AM Eastern This is a fair market value price provided by Massive. Learn more. Spyglass Pharma missed analyst earnings expectations in its Q3 2026 results, released November 12, 2026. The company reported EPS of -$0.73 versus the -$0.66 consensus estimate. Research:ProfileEarnings HistoryForecast Earnings Announcement Details QuarterQ3 2026Report DateNovember 12, 2026TimeAfter Market ClosesConference Call4:00 PM ET Spyglass Pharma EPS ResultsActual EPS-$0.73Consensus EPS -$0.66Beat/MissMissed by -$0.07One Year Ago EPSN/AEPS Beat Rate1 of last 4 quartersSpyglass Pharma Revenue ResultsActual RevenueN/AExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/AConference Call ResourcesPress Release (8-K)Quarterly Report (10-Q)SEC FilingEarnings HistoryCompany ProfilePowered by Earnings DocumentsPress Release(8-K)Quarterly report(10-Q) Spyglass Pharma Q3 2026 Earnings FAQ Did Spyglass Pharma beat earnings estimates for Q3 2026? Spyglass Pharma (NASDAQ:SGP) reported earnings of -$0.73 per share for Q3 2026, missing the consensus estimate of -$0.66. The report was announced on Thursday, November 12, 2026. Spyglass Pharma Earnings HeadlinesSpyGlass Pharma Q3 2026: Loss Widens as Build-Out Costs Surge45 minutes ago | 247wallst.comSpyGlass Pharma, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026November 11 at 7:19 PM | marketscreener.comMA free stock pick, from me to youElon's paid this chip supplier since 2012. When NVIDIA tried to buy the company, he fought the deal. Without its chip, his AI satellites don't fly. Now he wants 1,000,000 of them in orbit, 100 times what's up there today, and every one pays this company a royalty. Dylan believes shares could react by December 8th.November 12 at 1:00 AM | Behind the Markets (Ad)SpyGlass Pharma Reports Third Quarter 2026 Financial Results and Provides Corporate UpdatesNovember 11 at 4:05 PM | globenewswire.comStifel Nicolaus Sticks to Its Buy Rating for SpyGlass Pharma (SGP)November 9 at 7:10 AM | theglobeandmail.comSpyGlass Pharma (SGP) Stock Looks Pricey After Its 50% Monthly JumpNovember 8, 2026 | finance.yahoo.comSee More Spyglass Pharma Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Spyglass Pharma? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Spyglass Pharma and other key companies, straight to your email. Email Address About Spyglass PharmaSpyglass Pharma (NASDAQ:SGP) is a clinical-stage ophthalmology company developing sustained-release drug delivery systems for chronic eye diseases. Its research is focused on reducing reliance on patients’ regular use of eye drops. The company’s lead program is a bimatoprost drug delivery system being developed to treat glaucoma and ocular hypertension. Bimatoprost is a medication used to lower eye pressure, and SpyGlass is studying a delivery approach intended to provide treatment over an extended period. SpyGlass Pharma’s work centers on advancing this ophthalmic delivery platform and its lead program through clinical development. The company has not established a broad commercial product portfolio.View Spyglass Pharma ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Keeping AI Cool: AAON Rides the AI Heatwave to Record GrowthPalantir’s Real Washington Risk Isn’t the Budget—It’s OversightCan Constellation Energy's Contracts Power a Stock Rebound?IonQ Raised the Bar, But 3 Quantum Rivals Face Tough QuestionsAmazon's Rally Is Outpacing Big Tech, But Can AWS Justify the AI Spending?Aehr Test Systems Notches Another Post-Earnings Win as Sales Triple on AI DemandAST SpaceMobile Has a New Rocket Plan, But Its Cash-Burn Problem Isn't Going Away Upcoming Earnings Mizuho Financial Group (11/13/2026)Mitsubishi UFJ Financial Group (11/13/2026)Sumitomo Mitsui Financial Group (11/13/2026)Home Depot (11/17/2026)Walt Disney (11/17/2026)NVIDIA (11/17/2026)Lowe's Companies (11/18/2026)PDD (11/18/2026)TJX Companies (11/18/2026)Target (11/18/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
